Porin Deficiency or Plasmid Copy Number Increase Mediated Carbapenem-Resistant Escherichia coli Resistance Evolution. 2024

Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

This study investigated resistance evolution mechanisms of conjugated plasmids and bacterial hosts under different concentrations of antibiotic pressure. Ancestral strain ECNX52 was constructed by introducing the blaNDM-5-carrying IncX3 plasmid into E. coli C600, and was subjected to laboratory evolution under different concentrations of meropenem pressure. Minimal inhibitory concentrations and conjugation frequency were determined. Fitness of these strains was assessed. Whole genome sequencing and transcriptional changes were performed. Ancestral host or plasmids were recombined with evolved hosts or plasmids to verify plasmid or host factors in resistance evolution. Role of the repA mutation on plasmid copy number was determined. Two out of the four clones (EM2N1 and EM2N3) exhibited four-fold increase in MIC when exposed to a continuous pressure of 2 μg/mL MEM (1/32 MIC), by down regulating expression of outer membrane protein ompF. Besides, all four clones displayed four-fold increase in MIC and higher conjugation frequency when subjected to a continuous pressure of 4 μg/mL MEM (1/16 MIC), attributing to increasing plasmid copy number generated by repA D140Y (GAT→TAT) mutation. Bacterial hosts and conjugative plasmids can undergo resistance evolution under certain concentrations of antimicrobial pressure by reducing the expression of outer membrane proteins or increasing plasmid copy numbers.

UI MeSH Term Description Entries

Related Publications

Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
December 2009, Journal of chemotherapy (Florence, Italy),
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
June 2019, Acta microbiologica et immunologica Hungarica,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
March 2016, The Lancet. Infectious diseases,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
January 1994, Biotechnology progress,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
May 1985, The Journal of antimicrobial chemotherapy,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
November 2018, Microbial drug resistance (Larchmont, N.Y.),
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
January 1997, Plasmid,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
June 1982, Gene,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
September 2006, Antimicrobial agents and chemotherapy,
Guoxiu Xiang, and Zhiwei Zhao, and Shebin Zhang, and Yimei Cai, and Yuting He, and Jianming Zeng, and Cha Chen, and Bin Huang
January 2017, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!